The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex multi-step synthetic process. Early routes focused on amino acid chain section coupling, utilizing https://gregorygurw780178.ttblogs.com/20623142/synthesis-and-investigation-uses-of-retatrutide